ストックスクリーナーアプリを入手
2.33
0.34%
-0.008
前日終値:
$2.338
開ける：
$2.18
24時間の取引高:
5,223
Relative Volume:
0.33
時価総額：
$4.21M
収益：
-
当期純損益:
$-2.77M
株価収益率:
-0.8804
EPS:
-2.6464
ネットキャッシュフロー:
$-2.69M
1週間 パフォーマンス:
+3.10%
1か月 パフォーマンス:
+9.91%
6か月 パフォーマンス:
+13.66%
1年 パフォーマンス:
-42.07%
1日の値動き範囲:
$2.18
$2.34
1週間の範囲:
$2.16
$2.64
52週間の値動き範囲:
$1.725
$7.05
Xortx Therapeutics Inc Stock (XRTX) Company Profile
Compare XRTX vs VRTX, REGN, ARGX, MRNA, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XRTX
Xortx Therapeutics Inc
|
2.32 | 3.67M | 0 | -2.77M | -2.69M | -2.6464 |
VRTX
Vertex Pharmaceuticals Inc
|
546.91 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
810.84 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,030.86 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
141.91 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.68 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Xortx Therapeutics Inc (XRTX) 最新ニュース
XORTX Therapeutics Files August Form 6-K Highlighting Stronger June 2026 Balance Sheet - TipRanks
Going-concern warning at XORTX (XRTX) as losses mount - Stock Titan
XORTX Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
XORTX Therapeutics (XRTX) Advances 5.28% as Shares Test Resistance at $2.38Institutional Sentiment - vinanet.vn
XORTX (XRTX) Q1 2024 Earnings: Loss of -$1.24 per Share Misses Consensus by 372.2%Earnings Revision Upgrade - vinanet.vn
XORTX Therapeutics Announces Resignation of Board Chairman Anthony Giovinazzo - The Globe and Mail
XORTX Therapeutics (XRTX) Edges Higher at $2.21 as Shares Hold Mid-Range PositionModified Schiff - vinanet.vn
Board chair exit at XORTX Therapeutics (NASDAQ: XRTX) detailed - Stock Titan
XORTX Therapeutics (XRTX) Climbs 4.92% as Shares Approach Key Resistance at $2.23Fibonacci Retracement - dars.gov.et
XORTX Therapeutics (XRTX) Climbs 4.92% to $2.12 as Speculative Interest BuildsSwing Entry Signals - dars.gov.et
XORTX Therapeutics Inc. Announces Resignation of Anthony Giovinazzo from Director Role - marketscreener.com
XORTX Director Anthony Giovinazzo Steps Down for Personal Reasons - Stock Titan
XORTX Therapeutics Adds Independent Director to Strengthen Board Oversight - TipRanks
XORTX Therapeutics (NASDAQ: XRTX) appoints Depesh Narotam as independent director - Stock Titan
XORTX Appoints New Director - GlobeNewswire
XORTX Board Gains Director With Over 20 Years in Financial Services - Stock Titan
XORTX Therapeutics, Inc. Revenue Breakdown – TSXV:XRTX - TradingView
Vectus Biosystems Appoints Dr Tara Speranza as CEO and CTO, Raises $791,000 to Accelerate VB0004 Clinical Development - Kalkine
Why XORTX Therapeutics Inc stock is sliding today - Wealth Awesome
XORTX Therapeutics Inc (XRTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
XORTX Therapeutics Inc (XRTX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
XRTX|XORTX Therapeutics Inc|Price:2.025|Chg%:-0.090 - TradingKey
XRTX|XORTX Therapeutics Inc|Price:2.015|Chg%:-0.010 - TradingKey
XORTX Therapeutics Inc (XRTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
XORTX Therapeutics Inc (XRTX) Institutional Confidence - TradingKey
XORTX Therapeutics Inc (XRTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
XORTX Therapeutics Inc (XRTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
XORTX Therapeutics Inc. Revenue Breakdown – NASDAQ:XRTX - TradingView
XORTX Therapeutics Inc (XRTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
XORTX Therapeutics, Inc. Revenue Breakdown – NEO:XRTX - TradingView
XORTX Therapeutics(XRTX) Stock Options Chain | Quotes & News - Moomoo
XORTX Therapeutics (XRTX) Investor presentation Summary - Quartr
XORTX Therapeutics (XRTX) Q4 2024 earnings summary - Quartr
Price to earnings forward of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
XORTX Therapeutics (XRTX) Rallies 3.3% as Biotech Sector Gains MomentumMoney Flow - dars.gov.et
XORTX Therapeutics (XRTX) Gains 3.33% as Biotech Momentum BuildsDescending Triangle - dars.gov.et
XRTX Q1 2024 Earnings: Pre‑Revenue Biotech Reports EPS Miss as Clinical Pipeline AdvancesDiluted EPS Report - dars.gov.et
XORTX Therapeutics Inc. (XRTX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Xortx Therapeutics updates investors on kidney disease focus - ad-hoc-news.de
XORTX Therapeutics Company Profile & Introduction - Moomoo
XRTX Q1 2024 Earnings: Significant EPS Miss Reflects Preclinical Stage ChallengesQuarterly Earnings - dars.gov.et
Enterprise value to EBIT forward of XORTX Therapeutics, Inc. – TSXV:XRTX - TradingView
Price to sales forward of XORTX Therapeutics, Inc. – TSXV:XRTX - TradingView
Enterprise value to revenue forward of XORTX Therapeutics, Inc. – TSXV:XRTX - TradingView
Why XORTX Therapeutics Inc stock is skyrocketing today - Wealth Awesome
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
XRTX Q1 2024 Earnings: Significant EPS Miss Highlights Challenges in Clinical-Stage BiotechEarnings Growth Analysis - dars.gov.et
XRTX Q1 2024 Earnings: Significant EPS Miss Amid Operational DevelopmentsEarnings Surprise Stocks - DonanımHaber
XORTX Therapeutics (XRTX) Edges Higher as Stock Remains Within Defined RangeVolume Gap - dars.gov.et
XORTX Therapeutics Inc. (XRTX) Slides 2.79% as Shares Test Key Support Near $2.00Stock Surge Alerts - dars.gov.et
Xortx Therapeutics Inc (XRTX) 財務データ
収益
当期純利益
現金流量
EPS
0.55%
0.98%
大文字化:
|
ボリューム (24 時間):